Jiangxi Institute of Biological Products Inc. (HKG:6915)
Hong Kong · Delayed Price · Currency is HKD 10.74
+0.45 (4.37%)
At close: Oct 7, 2026
HKG:6915 Revenue
Jiangxi Institute of Biological Products had revenue of 41.65M CNY in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 219.00M. In the year 2025, Jiangxi Institute of Biological Products had annual revenue of 235.41M with 6.64% growth. That makes Jiangxi Institute of Biological Products the world's 30,891st largest company by revenue and 1,857th in Hong Kong.
Revenue (ttm)
219.00M CNY
Revenue Growth
+6.64%
P/S Ratio
13.10
Revenue / Employee
627.49K CNY
Employees
349
Market Cap
3.31B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 235.41M | 14.65M | 6.64% |
| Dec 31, 2024 | 220.76M | 22.73M | 11.48% |
| Dec 31, 2023 | 198.02M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.